Table 4.
Survival and shedding of immunized chickens after challenge
Immunized groups | HI titer(log2) | Challenge virus |
Positive samples/Total samples |
Shedding protection(%) | Mortality(%) | |||||
---|---|---|---|---|---|---|---|---|---|---|
1 d.p.c. |
3 d.p.c. |
5 d.p.c. |
||||||||
Oc | Cd | O | C | O | C | |||||
rGD4 | 8.70a(±1.22) | GD4 | 0/10 | 0/10 | 0/10 | 0/10 | 1/10 | 2/10 | 80 | 0 |
6.85b(±1.63) | JD/17 | 0/10 | 0/10 | 2/10 | 0/10 | 3/10 | 2/10 | 70 | 0 | |
rGD4HALo- mH3-NA-TX |
8.60a(±1.60) | GD4 | 0/10 | 0/10 | 0/10 | 0/10 | 1/10 | 0/10 | 90 | 0 |
7.25b(±1.55) | JD/17 | 0/10 | 0/10 | 1/10 | 0/10 | 2/10 | 0/10 | 80 | 0 | |
PBS | NDe | GD4 | 3/10 | 0/10 | 6/6 | 6/6 | NSf | NS | 0 | 100 |
ND | JD/17 | 6/10 | 0/10 | 8/10 | 8/10 | 10/10 | 6/10 | 0 | 0 |
d.p.c. days post-challenge; a HI titer against GD4; b HI titer against JD/17; c Oropharyngeal swab; d Cloacal swab; e No detection; f No survivors.